Breast Neoplasms
📧 Sign up to get email alerts when something new happens for Breast Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
This entry announces a recruiting clinical trial evaluating ATUSA ultrasound imaging for breast lesion evaluation (AUDIBLE), sponsored by iS…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models
A recruiting clinical trial to build a benchmark for breast ultrasound AI interpretation and evaluate multimodal AI models.
-
EMA approval · 2026-03-02EMA Authorised: Herceptin (trastuzumab) — Roche Registration GmbH
The EMA authorised Herceptin (trastuzumab) for stomach neoplasms and breast neoplasms. The marketing authorization holder is Roche Registrat…
-
EMA approval · 2026-02-24EMA Authorised: Eribulin Baxter (Eribulin mesylate) — Baxter Holding B.V.
EMA authorised Eribulin Baxter (eribulin mesylate) for treatment of breast neoplasms and liposarcoma; the marketing authorisation holder is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Dissemination of BREASTChoice AIM1-B [NA]
This clinical trial update indicates that recruitment is ongoing for the BREASTChoice AIM1-B study related to breast cancer, disseminated by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-02-03EMA Authorised: Trazimera (trastuzumab) — Pfizer Europe MA EEIG
The EMA has authorised Trazimera (trastuzumab) for stomach and breast neoplasms, with Pfizer Europe MA EEIG as the marketing authorization h…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Randomized Trial of Accelerated Partial Breast Irradiation [NA]
This clinical trial update notes the completion of a randomized study evaluating accelerated partial breast irradiation for breast neoplasms…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Self-Affirmation Intervention After Mastectomy [NA]
A self-affirmation intervention trial for patients after mastectomy due to breast cancer is not yet recruiting.
-
EMA approval · 2026-01-06EMA Authorised: Tyverb (lapatinib) — Novartis Europharm Limited
The European Medicines Agency has authorised Tyverb (lapatinib) for breast neoplasms. The marketing authorisation holder is Novartis Europha…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound [NA]
The update notes that the clinical trial NCT07287111 evaluating CadAI-B Dx for decision support in breast ultrasound has completed; results …
-
EMA approval · 2025-12-03EMA Authorised: Enhertu (trastuzumab deruxtecan) — Daiichi Sankyo Europe GmbH
The EMA authorised Enhertu (trastuzumab deruxtecan) for breast neoplasms with conditional approval, issued to Daiichi Sankyo Europe GmbH; de…
-
EMA approval · 2025-11-27EMA Authorised: Lynkuet (elinzanetant) — Bayer AG
The European Medicines Agency authorised Lynkuet (elinzanetant) from Bayer AG for menopausal symptoms including hot flashes and indications …
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Health Belief Model-Based Survey on Breast Self-Examination Awareness and Practice Among Community-Dwelling Middle-Aged and Older Women
A clinical trial update describing a health belief model-based survey to assess awareness and practice of breast self-examination among comm…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade [NA]
An ongoing clinical trial evaluating the effect of different ropivacaine concentrations on pulmonary ventilation during intercostal nerve bl…
-
EMA approval · 2025-07-11EMA Authorised: Capecitabine Teva (capecitabine) — Teva Pharma B.V.
EMA authorised Capecitabine Teva (capecitabine), a generic capecitabine product by Teva Pharma B.V., for multiple cancer indications, includ…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Comparison of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block [NA]
Clinical trial completed comparing Erector Spinae Plane Block versus Serratus Posterior Superior Intercostal Plane Block for analgesia in br…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy [NA]
Clinical trial update on the use of indocyanine green fluorescence (ICG-F) to guide breast-conserving surgery after preoperative chemotherap…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Comparative Evaluation of Diffusion Weighted MRI And Ultrasonography In The Detection of Breast Lesions
A comparative study evaluates diffusion-weighted MRI versus ultrasonography for detecting breast lesions; the trial is sponsored by Superior…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
A clinical trial update reports the development of an ultrasonic sensor-based assist tool for breast examination, sponsored by Seoul Nationa…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction [Phase 2]
A phase II randomized trial evaluating omitting chest wall radiotherapy after prosthetic reconstruction in breast cancer patients; the study…
-
EMA approval · 2024-10-11EMA Authorised: Halaven (Eribulin) — Eisai GmbH
The EMA authorised Halaven (eribulin) for breast neoplasms and liposarcoma under Eisai GmbH, with a decision date of 26 July 2024.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: The Application of Pectoral Nerve II(PECS II)block in Breast Fibroadenoma Resection Surgery [NA]
The update describes the use of PECS II nerve block during breast fibroadenoma resection surgery and notes the trial status as completed.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies [NA]
An ongoing French clinical trial is evaluating self-hypnosis techniques (anchoring and conversational hypnosis), used alone or in combinatio…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: High-intensity Exercise After Treatment [NA]
This clinical trial investigating high-intensity exercise after breast cancer treatment was terminated.
-
EMA approval · 2024-08-28EMA Authorised: Ibandronic Acid Teva (ibandronic acid) — Teva Pharma B.V.
EMA authorised Teva's ibandronic acid with indications including postmenopausal osteoporosis, breast neoplasms, neoplasm metastasis, and bon…